Trademark Overview
On Thursday, July 2, 2026, a trademark application was filed for IZWUNLY with the United States Patent and Trademark Office. The USPTO has given the IZWUNLY trademark a serial number of 99918597. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 2, 2026. This trademark is owned by Intellia Therapeutics, Inc.. The IZWUNLY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use as a gene editing therapy; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical and biological preparations for treating and managing hereditary angioedema (HAE) and complications caused by hereditary angioedema (HAE); Pharmaceutical and biological preparations for use as a one-time treatment for hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (Type 1 or Type 2); Pharmaceutical and biological preparations for use as a gene editing therapy that inactivates the KLKB1 gene and lowers plasma prekallikrein levels; Pharmaceutical and biological preparations for use as a gene editing therapy for hereditary angioedema (HAE); Pharmaceutical and biological preparations, namely, gene editing preparations for treating and managing swelling attacks; Therapeutic agents in the nature of a CRISPR/Cas9 system for treating hereditary angioedema (HAE)
